Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Pfizer, on the other hand, with its improving growth prospects, rising estimates, cheaper valuation, and higher dividend ...

The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its tariff rollout because it could hurt Lilly’s business and the ...

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. Stream NBC 5 for free, 24/7, wherever you are. The Danish drugmaker on Friday ...

The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the regulator said on Friday, making the device the first of its kind to detect ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

The Trump administration wants to bring the production of more drugs, including medicines like antibiotics that may be in ...

Eli Lilly seems to have responded to the threat by President Donald Trump of tariffs on the pharma industry if they don't relocate their manufacturing operations to the US. The pharma group has ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...